The axillary hyperhidrosis treatment market was valued at USD 1.9 billion in 2025, is projected to reach USD 3.4 billion by 2035 and is forecast to register a 6.0% CAGR between 2025 and 2035. In 2025, drug therapy holds 65.0% of treatment sales and retail pharmacy chains represent 35.0% within the distribution channel segment.